# Antioxidant Use in Diabetes to Reduce Oxidative Stress

> **NCT03056014** · EARLY_PHASE1 · TERMINATED · sponsor: **University of Maryland, Baltimore** · enrollment: 8 (actual)

## Conditions studied

- Ameliorating Oxidative Stress in Type 1 Diabetes

## Interventions

- **DRUG:** N-acetyl cysteine
- **DIETARY_SUPPLEMENT:** omega 6 Fish oil ( PUFA)
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT03056014
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-11-01
- **Primary completion:** 2020-03-12
- **Final completion:** 2020-03-12
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** COVID
- **Last updated:** 2022-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03056014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03056014, "Antioxidant Use in Diabetes to Reduce Oxidative Stress". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03056014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*